| Literature DB >> 31701081 |
Shantanu Kumar Kar1, Jyotsnamayee Sabat2, Lal M Ho2, Rasmi Arora3, Bhagirathi Dwibedi4.
Abstract
Purpose: The primitive tribal groups (PTGs) need special attention because of their low population growth: declining population size with high mortality rates. Scanty reports are available on the prevalence of hepatitis C virus (HCV) infection in primitive tribes of the country emphasizing their cultural and social practices associated with transmission of the disease.Entities:
Keywords: HCV; primitive tribe; risk factor
Year: 2019 PMID: 31701081 PMCID: PMC6830531 DOI: 10.1089/heq.2019.0005
Source DB: PubMed Journal: Health Equity ISSN: 2473-1242

Distribution of PTGs in six districts of Odisha. PTGs, primitive tribal groups.
Anti-Hepatitis C Virus Prevalence (%) in Different Age Groups
| Tribe wise prevalence/distribution | |||||
|---|---|---|---|---|---|
| Age group | Lodha ( | Khadia ( | Mankidia ( | Juanga ( | Total, +ve (%) |
| 0–5 | 0 (0) | 1 (3.8) | 1 (1.9) | 1 (2.6) | 3 (11.11) |
| 6–15 | 1 (12.5) | 1 (3.8) | 8 (14.8) | 20 (51.3) | 30 (23.6) |
| 16–30 | 1 (12.5) | 9 (34.6)[ | 16 (29.6) | 6 (15.4) | 32 (25.2) |
| 31–45 | 3 (37.5) | 9 (34.6)[ | 17 (31.5)[ | 6 (15.4) | 35 (27.5)[ |
| 46–60 | 3 (37.5) | 3 (11.5) | 6 (11.1) | 3 (7.7) | 15 (11.8) |
| >60 | 0 (0) | 3 (11.5) | 6 (11.1) | 3 (7.7) | 12 (9.4) |
| Total | 8 (3.3) | 26 (5.7) | 54 (13.4) | 39 (8.4) | 127 (7.1) |
The Saora tribe has zero antibody prevalence, hence not included in the table.
p<0.05 (chi-square test comparing age-specific prevalence in the respective tribes); % prevalence was calculated, taking the No. of individuals tested in the respective age group as the denominator.
Distribution of Associated Risk Factors Among Primitive Tribal Groups with Respect to Sero Status of Hepatitis C Virus
| Tribe wise prevalence/distribution | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lodha ( | Khadia ( | Mankidia ( | Juanga ( | |||||||||
| Associated risk factors | Total No. (%) | HCV +ve (%) | OR (95% CI) | Total No. (%) | HCV +ve (%) | OR (95% CI) | Total No. (%) | HCV +ve (%) | OR (95% CI) | Total No. (%) | HCV +ve (%) | OR (95% CI) |
| Tattooing | 18 (7.4) | 0 (0) | 1.30 (0) | 57 (12.7) | 4 (7.02) | 1.06 (0.32–3.46) | 135 (33.6) | 22 (16.30) | 0.68 (0.27–1.68) | 61 (13.3) | 4 (6.56) | 0.73 (0.20–2.67) |
| Sharing of razor | 18 (7.4) | 2 (11) | 0.10 (0.01–1.17) | 132 (29.3) | 10 (7.58) | 0.53 (0.01–33.69) | 86 (21.4) | 19 (22) | 0.23 (0.10–0.54)[ | 61 (13.3) | 11 (18) | 0.01[ |
| Body piercing | 62 (25.6) | 4 (6.45) | 0.14 (0.021–1.01) | 193 (42.9) | 15 (7.77) | 0.36 (0.13–0.92) | 181 (45.13) | 29 (16) | 0.48 (0.19–1.21) | 212 (46.1) | 11 (5.19) | 1.98 (0.81–4.86) |
| History of multiple injections | 56 (23.1) | 1 (1.8) | 0.40 (0.04–4.20) | 274 (60.9) | 20 (7.30) | 2.63 (0.59–11.65) | 241 (60.1) | 37 (15.35) | 0.96 (0.25–3.68) | 247 (53.7) | 17 (6.88) | 0.09 (0.01–0.61) |
| Shaving by village barber | 77 (31.8) | 3 (3.9) | 0.75 (0.07–8.21) | 133 (29.6) | 10 (7.52) | 0.71 (0.01–44.58) | 86 (21.4) | 19 (22) | 0.41 (0.22–0.77)[ | 99 (21.5) | 12 (12.12) | 3.09 (0.36–26.5) |
| Male | 144 | 4 | 1.48 (0.36–6.1) | 226 | 12 | 1.18 (0.53–2.63) | 195 | 27 | 0.93 (0.52–1.66) | 229 | 26 | 0.46 (0.23–0.93)[ |
| Female | 98 | 4 | 224 | 14 | 206 | 27 | 221 | 13 | ||||
p<0.05.
CI, confidence interval; HCV, hepatitis C virus; OR, odds ratio.